Damien Gallagher1, Alex Kiss2, Krista Lanctot3, Nathan Herrmann1. 1. Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada. 2. Sunnybrook Research Institute and Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. 3. Sunnybrook Research Institute and Departments of Psychiatry, Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: It has been proposed that inflammation may be causally related to depression. If this is the case, it may be possible to distinguish an inflammatory depressive subtype according to illness course, pattern of co-morbidity and symptom profile. METHODS: Eight hundred and eleven community dwelling older adults with depression (8 item Center for Epidemiologic Studies scale ≥ 4) from the English Longitudinal study of Ageing (ELSA) were followed for a median of 47 months. Participants with depression and inflammation (C Reactive Protein > 3 mg/l) were compared to those with depression alone. RESULTS: In a longitudinal analysis, depression with associated inflammation was more likely to persist over time. This association was independent of baseline depression severity and medical co-morbidity (OR 1.47 95% CI 1.03 - 2.10, p = 0.034) but was no longer significant following further adjustment for body mass index (OR 1.37 95% CI 0.94 - 2.01, p = 0.106). Inflammation either partially or completely mediated the association between medical co-morbidity, body mass index and depression at follow-up. Depression with inflammation was associated with more amotivation, less sadness, greater medical co-morbidity and higher body mass index. CONCLUSIONS: Our findings provide some support for an inflammatory contribution to depression. This subgroup has a worse prognosis and may benefit from interventions targeting co-morbidity, body mass index and associated inflammation.
OBJECTIVE: It has been proposed that inflammation may be causally related to depression. If this is the case, it may be possible to distinguish an inflammatory depressive subtype according to illness course, pattern of co-morbidity and symptom profile. METHODS: Eight hundred and eleven community dwelling older adults with depression (8 item Center for Epidemiologic Studies scale ≥ 4) from the English Longitudinal study of Ageing (ELSA) were followed for a median of 47 months. Participants with depression and inflammation (C Reactive Protein > 3 mg/l) were compared to those with depression alone. RESULTS: In a longitudinal analysis, depression with associated inflammation was more likely to persist over time. This association was independent of baseline depression severity and medical co-morbidity (OR 1.47 95% CI 1.03 - 2.10, p = 0.034) but was no longer significant following further adjustment for body mass index (OR 1.37 95% CI 0.94 - 2.01, p = 0.106). Inflammation either partially or completely mediated the association between medical co-morbidity, body mass index and depression at follow-up. Depression with inflammation was associated with more amotivation, less sadness, greater medical co-morbidity and higher body mass index. CONCLUSIONS: Our findings provide some support for an inflammatory contribution to depression. This subgroup has a worse prognosis and may benefit from interventions targeting co-morbidity, body mass index and associated inflammation.
Authors: Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Marco Solmi; Michele Fornaro; Brisa S Fernandes; Christoph Mueller; Trevor Thompson; André F Carvalho; Stefania Maggi Journal: Int J Geriatr Psychiatry Date: 2017-08-06 Impact factor: 3.485
Authors: Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker Journal: Neuropsychol Rev Date: 2020-01-15 Impact factor: 7.444
Authors: Emanuele Felice Osimo; Luke James Baxter; Glyn Lewis; Peter B Jones; Golam M Khandaker Journal: Psychol Med Date: 2019-07-01 Impact factor: 7.723
Authors: May A Beydoun; Hardeep K Obhi; Jordan Weiss; Jose A Canas; Hind A Beydoun; Michele K Evans; Alan B Zonderman Journal: Mol Psychiatry Date: 2019-04-24 Impact factor: 15.992
Authors: Maria Grazia Morgese; Maria Bove; Matteo Francavilla; Stefania Schiavone; Stefania Dimonte; Anna Laura Colia; Matteo Bevilacqua; Luigia Trabace; Paolo Tucci Journal: Biomolecules Date: 2021-05-03
Authors: K J E Kokkeler; R M Marijnissen; K J Wardenaar; D Rhebergen; R H S van den Brink; R C van der Mast; R C Oude Voshaar Journal: Psychol Med Date: 2020-07-03 Impact factor: 7.723